- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 5/08 - Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Patent holdings for IPC class A61P 5/08
Total number of patents in this class: 74
10-year publication summary
|
2
|
2
|
1
|
4
|
4
|
6
|
5
|
5
|
7
|
12
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Spruce Biosciences, Inc. | 49 |
9 |
| Bayer Intellectual Property GmbH | 2357 |
8 |
| Crinetics Pharmaceuticals, Inc. | 132 |
6 |
| Antisense Therapeutics Ltd. | 24 |
3 |
| Endo Pharmaceuticals Solutions Inc. | 22 |
3 |
| Shanghai Scizeng Medical Technology Co., Ltd. | 15 |
3 |
| The Regents of the University of California | 20815 |
2 |
| Mars, Incorporated | 2891 |
2 |
| Bayer Schering Pharma AG | 309 |
2 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 173 |
2 |
| Edix SA | 10 |
2 |
| Aeterna Zentaris GmbH | 39 |
1 |
| Beijing Neurosurgical Institute | 34 |
1 |
| Biotropics Malaysia Bhd | 24 |
1 |
| Dicerna Pharmaceuticals, Inc. | 180 |
1 |
| Emory University | 1723 |
1 |
| Icahn School of Medicine at Mount Sinai | 1045 |
1 |
| ISR Immune System Regulation AB | 1 |
1 |
| Kissei Pharmaceutical Co., Ltd. | 178 |
1 |
| Maatschap Interne Geneeskunde Rijnstate | 1 |
1 |
| Other owners | 23 |